Creative Medical Technology Holdings, Inc.
CELZ
$1.04
-$0.04-3.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 21.54% | -34.99% | |||
| Depreciation & Amortization | -20.76% | -6.47% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.06% | -25.12% | |||
| Operating Income | -7.06% | 25.01% | |||
| Income Before Tax | -7.67% | 25.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.67% | 25.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 50.00% | -- | |||
| Net Income | -7.61% | 25.57% | |||
| EBIT | -7.06% | 25.01% | |||
| EBITDA | -7.61% | 25.30% | |||
| EPS Basic | -7.61% | 46.02% | |||
| Normalized Basic EPS | -7.58% | 45.98% | |||
| EPS Diluted | -7.61% | 46.02% | |||
| Normalized Diluted EPS | -7.58% | 45.98% | |||
| Average Basic Shares Outstanding | 0.00% | 37.90% | |||
| Average Diluted Shares Outstanding | 0.00% | 37.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||